Skip to main navigation Skip to search Skip to main content

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

  • Isobella Honeyborne (Contributor)
  • Timothy D. McHugh (Contributor)
  • Iitu Kuittinen (Contributor)
  • Anna Cichonska (University of Helsinki) (Creator)
  • Dimitrios Evangelopoulos (Contributor)
  • Katharina Ronacher (Contributor)
  • Paul D. van Helden (Contributor)
  • Stephen H. Gillespie (Contributor)
  • Delmiro Fernandez-Reyes (Contributor)
  • Gerhard Walzl (Contributor)
  • Juho Rousu (Contributor)
  • Philip D. Butcher (Contributor)
  • Simon J. Waddell (Contributor)

Dataset

Filter
Article

Search results

  • 2016

    Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

    Honeyborne, I., McHugh, T. D., Kuittinen, I., Cichonska, A., Evangelopoulos, D., Ronacher, K., van Helden, P. D., Gillespie, S. H., Fernandez-Reyes, D., Walzl, G., Rousu, J., Butcher, P. D. & Waddell, S. J., 7 Apr 2016, In: BMC Medicine. 14, 1, p. 1-13 68.

    Research output: Contribution to journalArticleScientificpeer-review

    Open Access
    File
    42 Citations (Scopus)
    202 Downloads (Pure)